Reckitt Benckiser has upgraded its expected revenue for its core brands this year, following the implementation of a significant simplification drive last year. The FTSE 100 giant now expects like for ...

We go inside Reckitt’s real-world rollout of agentic AI with Empathy Lab – and explore why marketers need to stop waiting and ...

Reckitt Benckiser has a lot of attractive peers, and many of them are trading at much lower. The company's primary peers ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have ...

The stock traded 9% higher after the company’s core business posted revenue growth ahead of consensus expectations.

By Yadarisa Shabong (Reuters) -Consumer goods company Reckitt raised its annual revenue forecast on Thursday after second-quarter net sales growth topped expectations, sending shares soaring, as ...

Reckitt currently trades at a share price of around £64 (approximately $16 per ADR). This translates to a price-to-sales ratio of 3.4, slightly lower than the ten-year average multiple of 3.7.

Reckitt , maker of Dettol and Lysol cleaning products, on Wednesday missed third-quarter like-for-like sales expectations as volumes declined, but said it would start a 1 billion pound ($1.2 ...

Reckitt Benckiser is recalling 145,000 cans of baby formula for possible cross-contamination with Cronobacter sakazakii. The company's recall was issued out of an abundance of caution.

Consumer goods giant Reckitt Benckiser RKT-0.04%decrease; red down pointing triangle isn’t exactly in limbo, even as it awaits a new chief executive. The maker of Lysol and Clearasil posted ...

Reckitt Benckiser is pulling Suboxone tablets, which lost patent protection, from the US market, claiming children can be accidentally harmed, but won't do so for a few months. Meanwhile, Reckitt ...